Drugs / Estrofem
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT01237535 | Nov 2011 → Nov 2013 | male infertility | Rabin Medical Center | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT04797338 Comparator | Dec 2017 → Sep 2021 | ovarian hyperstimulation syndrome, pregnancy disorder with abortive outcome | Assaf-Harofeh Medical Center | Unknown | No outcome recorded |
| — | NCT03540979 Comparator | Jun 2018 → Dec 2019 | — | Meir Medical Center | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Estrofem | “Luteal support with estrogen + progesterone \[(Crinone 8% vaginal gel; Serono, Israel) and Estrofem 4mg\]” NCT01237535 ↗ |